Medofloxine (Ofloxacin)

Ofloxacin works by binding to bacterial DNA gyrase and topoisomerase IV, enzymes that control DNA supercoiling and replication. Inhibiting these enzymes stops bacterial DNA synthesis and transcription, leading to bacterial cell death. This mechanism gives ofloxacin a broad spectrum of activity against many Gram‑negative and some Gram‑positive bacteria.

The dosage of Medofloxine is individualized by the prescriber based on the type and severity of the infection, patient age, weight, and renal function. Physicians determine the appropriate strength, frequency, and length of therapy to achieve optimal clinical outcomes.

Safety of ofloxacin during pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medofloxine (ofloxacin) shares the class‑wide mechanism of DNA gyrase inhibition with other fluoroquinolones but differs in its pharmacokinetic profile, spectrum of activity and tissue penetration. Compared with ciprofloxacin, ofloxacin may have slightly better activity against certain Gram‑positive organisms, while still covering many Gram‑negative pathogens.

Medofloxine should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not store in humid or excessively hot environments.

Medofloxine is administered orally, typically as tablets or capsules, and should be taken with a full glass of water. It may be taken with or without food, but patients should avoid concurrent intake of antacids or mineral supplements that can reduce absorption.

Serious risks include tendon rupture (especially in the Achilles), QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, peripheral neuropathy, and hepatic injury. Patients should seek immediate medical attention if they experience any of these symptoms.

Medofloxine is contraindicated in individuals with a known hypersensitivity to ofloxacin or other fluoroquinolones, patients with a history of tendon disorders related to fluoroquinolone use, and those taking medications that significantly prolong the QT interval. It should also be used with caution in pregnant or lactating women, the elderly, and patients with severe renal impairment.